Cabozantinib Market: Innovation, Demand and Future Industry Landscape 2034
The Cabozantinib Market is closely associated with the management of renal cell carcinoma. Continued demand for systemic treatments for advanced kidney cancer supports the use of established targeted therapies within oncology care. The Cabozantinib Market was valued at US$ 1.46 billion in 2025 and is expected to reach US$ 2.67 billion by 2034, registering a CAGR of 6.94% during 2026–2034....
0 Комментарии 0 Поделились 270 Просмотры 0 предпросмотр